Market Research Logo

Brazil Pharmaceuticals and Healthcare Report Q2 2016

Brazil Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Brazil will continue to be the most important market for multinational pharmaceuticalcompanies in Latin America, despite growing financial tensions, increasing pricing pressure and genericcompetition. Headline Expenditure Projections

Pharmaceuticals: BRL65.8bn (USD19.8bn) in 2015 to BRL69.8bn (USD18.4bn) in 2016; +6.1% in localcurrency terms and -7.0% in US dollar terms. Forecast in has stayed the same as in Q116.

Healthcare: BRL509.9bn (USD216.7bn) in 2015 to BRL601.1bn (USD158.2bn) in 2016; +8.3% in localcurrency terms and -5.0% in US dollar terms. Forecast in local currency has been revised downward fromQ116.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Brazil 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Brazil 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Brazil 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Brazil 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Brazil 2014-2020)
Industry Risk/Reward Index
Americas Risk/Reward Index
Brazil Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Brazil 2010-2015)
Table: Healthcare Personnel (Brazil 2010-2015)
Table: Healthcare Activity (Brazil 2010-2015)
Research & Development
Biotechnology
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Top 10 Pharmaceutical Companies In Brazil By Sales In 2013
Table: Multinational Pharmaceutical Company Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Aché/Biosintética
Cristália
EMS Sigma
Eurofarma
GlaxoSmithKline
Table: GlaxoSMITHKLINE'S Strong Collaborative Efforts In Public-Private Partnerships (Ppps) In Brazil
Medley
Merck & Co
Novartis
Pfizer
Roche
Sanofi
Demographic Forecast
Table: Population Headline Indicators (Brazil 1990-2025)
Table: Key Population Ratios (Brazil 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Brazil 1990-2025)
Table: Population By Age Group (Brazil 1990-2025)
Table: Population By Age Group % (Brazil 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report